跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,100 条关于
“ALPHA3”
全部
2,100
临床试验
1,402
药物
562
机构
16
资讯
120
去年
Allogene Therapeutics Modifies ALPHA3 Trial Design Following Patient Death, Adopts Standard Lymphodepletion Protocol
去年
Allogene Therapeutics' ALPHA3 Trial: CAR-T Therapy Guided by MRD Testing for LBCL
去年
Allogene Pauses Cema-Cel Trial Enrollment, Prioritizes Other Programs
去年
Allogene and Foresight Diagnostics Forge $37.3M Partnership for Lymphoma Diagnostic Development
2年前
Allogene Therapeutics Pivots Strategy with Pipeline Restructuring and 22% Workforce Reduction
9个月前
Allogene Secures Full Control of CAR-T Therapy Following Favorable Arbitration Ruling
去年
Allogene Therapeutics Advances AlloCAR T Pipeline in Oncology and Autoimmune Diseases
去年
Allogene Therapeutics Reports Narrowed Q2 Loss Despite Clinical Trial Delays for CAR-T Programs
去年
Allogene Therapeutics Halts Enrollment in Leukemia Trial Cema-Cel Due to Slow Recruitment
去年
Foresight Diagnostics Sets Strategic Goals for 2025 Following a Year of Significant Achievements
第 1 页,共 12 页
上一页
下一页